Perlyn Z. Kwek
10 Biopolis Road, Chromos #05-01
Singapore, 138670, Singapore
Singapore, 138670, Singapore
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Correction to "Discovery of an Orally Bioavailable Reversible Covalent SARS-CoV-2 Mpro Inhibitor with Pan-Coronavirus Activity".
Journal: Journal of medicinal chemistry
Published: December 23, 2025
In Silico-Enabled Discovery and Development of Potent and Selective CDK11 Inhibitors.
Journal: ChemMedChem
Published: October 08, 2025
Discovery of an Orally Bioavailable Reversible Covalent SARS-CoV-2 Mpro Inhibitor with Pan-Coronavirus Activity.
Journal: Journal of medicinal chemistry
Published: August 07, 2025
Strategic Design of Catalytic Lysine-Targeting Reversible Covalent BCR-ABL Inhibitors*.
Journal: Angewandte Chemie (International ed. in English)
Published: April 20, 2021
Stepwise Evolution of Fragment Hits against MAPK Interacting Kinases 1 and 2.
Journal: Journal of medicinal chemistry
Published: January 08, 2020
Optimization of Selective Mitogen-Activated Protein Kinase Interacting Kinases 1 and 2 Inhibitors for the Treatment of Blast Crisis Leukemia.
Journal: Journal of medicinal chemistry
Published: April 24, 2018
Backbone resonance assignments for the SET domain of human methyltransferase NSD3 in complex with its cofactor.
Journal: Biomolecular NMR assignments
Published: February 27, 2017
Discovery and characterisation of the automethylation properties of PRDM9.
Journal: The Biochemical journal
Published: December 06, 2016
Identification of covalent active site inhibitors of dengue virus protease.
Journal: Drug design, development and therapy
Published: December 18, 2015
Showing 1-10 of 10
Last Updated: 09/26/2026